VelorQ BrandRelay AI · RELAY Domain Model · UpLeap Technologies · Confidential
Pharma Brand Blueprint — Vantara Pharmaceuticals
RELAY's five-stage engine applied to a 4-brand pharmaceutical portfolio spanning cardiology, diabetes, respiratory and dermatology. This document defines what RELAY knows about each brand, how it tracks MLR and fair-balance obligations, and how it produces compliant HCP and patient content at scale. Ref. BR-2026-PHRM-VNT-0011.
4 Product Brands
MLR 3-Way Review
FDA OPDP Aligned
8 AI Agents
Live Since Feb 2026
4
Product brands onboarded
24+
Content formats supported
9
Active campaigns this quarter
Product Brands
| Brand | Therapeutic Area | Primary Audience | Indication | Brand Guide Status |
|---|
| Cardivea | Cardiology | Cardiologists, hypertensive adults | Hypertension & cholesterol management | ✓ Ingested |
| Glycomend | Diabetes & Metabolic | Endocrinologists, T2D patients | Type 2 diabetes management | ✓ Ingested |
| Respira | Respiratory | Pulmonologists, asthma/COPD patients | Asthma & COPD maintenance therapy | ✓ Ingested |
| Dermacare | Dermatology | Dermatologists, chronic skin condition patients | Moderate-to-severe eczema | ↻ Refresh due |
Regulatory & Compliance Frameworks Applied
FRAMEWORK · 01
MLR Three-Way Review
Every asset routes through simulated Medical, Legal and Regulatory checkpoints before it can be marked approval-ready.
FRAMEWORK · 02
FDA OPDP Promotional Guidelines
Enforces fair balance — every efficacy claim paired with corresponding risk information, no overstated benefit language.
FRAMEWORK · 03
ISI — Important Safety Information
Blocks publish on any consumer-facing asset missing the brand's current ISI / boxed warning snippet.
FRAMEWORK · 04
Off-Label Promotion Screen
Flags any claim referencing an indication, population or dosing outside the approved label.
Stage 1 · Understand — Building the Vantara Profile
RELAY builds a structured profile of Vantara's 4-brand portfolio — each brand's indication, label language, approved claims and audience — before any content work begins.
1
Brand Ingestion Agent
Parses each brand's style guide and current Prescribing Information (PI) — extracting approved claims, ISI text, logo lockups and tone-of-voice rules per brand.
2
Brand Mapping Agent
Registers all 4 brands with distinct therapeutic areas and audiences, so a single umbrella campaign concept can be adapted per brand rather than reused verbatim.
3
Compliance Framework Agent
Cross-references MLR review requirements, FDA OPDP fair-balance rules and off-label restrictions to build the active rule set for the Shield stage.
4
Voice Calibration Agent
Learns each brand's approved tone from historically MLR-approved assets, producing a tone fingerprint used to score every new draft.
Stage 2 · Scout — Live Market Intelligence
RELAY continuously scans the pharma marketing landscape relevant to each Vantara brand — competitor HCP campaigns, congress calendars, and disease-awareness observances — grounding strategy in what's happening now.
SOURCE TYPE
Competitor HCP Campaigns
Tracks 11 competing cardiology, diabetes, respiratory and dermatology brands across HCP portals and congress presence.
SOURCE TYPE
Disease Awareness Calendar
World Heart Day, Diabetes Awareness Month, Asthma Awareness Month, Eczema Awareness Month mapped to relevant brands.
SOURCE TYPE
Medical Congress Calendar
Upcoming cardiology, endocrinology, pulmonology and dermatology congresses with abstract deadlines and HCP attendance signals.
SOURCE TYPE
Patient Adherence Signals
Aggregated, de-identified adherence trend themes used to shape patient support messaging — never for individual targeting.
Stage 3 · Blueprint — Channel-by-Channel Content Plan
Example: RELAY's current plan for the umbrella Adherence Matters patient-support campaign, phased across channels and reskinned per brand.
| Channel | Asset Type | Primary Brand(s) | Phase | Status |
|---|
| Web / Landing Page | Campaign microsite | All 4 brands | Phase 1 — Awareness | Forged |
| Instagram / Facebook | Carousel + Reels storyboard | Cardivea (lead), all brands | Phase 1 — Awareness | Forged |
| LinkedIn | HCP detailing post | Cardivea, Glycomend | Phase 2 — HCP Detailing | In MLR Review |
| Email | Patient adherence sequence (3-part) | All 4 brands | Phase 2 — Adherence | Forging |
| YouTube / Video | 30s explainer + 15s cutdown | Cardivea (lead) | Phase 1 — Awareness | Forging |
| X (Twitter) | Announcement thread | All 4 brands | Phase 1 — Awareness | Forged |
| Print / In-Clinic Signage | Waiting-room poster with ISI panel | All 4 brands (localized) | Phase 1 — Awareness | Queued |
Stage 4 · Forge — The 8-Agent Roster
AGENT · 01
Copy Architect
Generates headlines, body copy and CTAs in each brand's calibrated tone, always paired with required risk language.
AGENT · 02
Visual Composer
Produces on-brand static ad layouts, social carousels and print-ready compositions with correct ISI placement.
AGENT · 03
Storyboard Director
Builds shot-by-shot video storyboards and scripts, reserving mandatory screen time for safety information.
AGENT · 04
Channel Adapter
Reformats a single approved concept into channel-native specs — aspect ratios, character limits, platform conventions.
AGENT · 05
Brand Localizer
Adapts a winning campaign concept across all 4 product brands — swapping indication detail, imagery and claims.
AGENT · 06
Brand Guardian
Scores every draft against the tone fingerprint and visual brand system before it reaches Shield.
AGENT · 07
MLR Compliance Screen
Runs the simulated Medical, Legal, Regulatory checkpoint; cites the specific label section on any flag.
AGENT · 08
Fair-Balance & ISI Auditor
Verifies every efficacy claim carries matching risk information and that ISI is present, legible and unedited.
Stage 5 · Shield — Two-Layer Verification
Brand Alignment Gate
MLR / Regulatory Gate
✓
Tone Match
Draft compared against the brand's tone fingerprint. Threshold: 90%+ match required to pass.
✓
Visual Consistency
Logo placement, color tokens and typography checked against each brand's style guide.
✓
Messaging Hierarchy
Confirms primary efficacy message leads, with brand-specific claims supporting rather than competing.
✓
Fair Balance Check
Blocks any asset where an efficacy claim appears without corresponding risk information.
✓
ISI Presence & Legibility
Confirms Important Safety Information is present, unedited, and meets minimum legibility requirements.
✓
Off-Label Screen
Flags any claim referencing an indication, population or dosing outside the approved label — cites the label section.